Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis.
about
Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cellsNatural history of chronic hepatitis B virus infection from infancy to adult life - the mechanism of inflammation triggering and long-term impactsThe Immunodominant Influenza A Virus M158-66 Cytotoxic T Lymphocyte Epitope Exhibits Degenerate Class I Major Histocompatibility Complex Restriction in HumansIdentification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.Development of an epitope conservancy analysis tool to facilitate the design of epitope-based diagnostics and vaccines.HLA class I supertypes: a revised and updated classification.HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease.CD8(+) lymphocytes from simian immunodeficiency virus-infected rhesus macaques recognize 14 different epitopes bound by the major histocompatibility complex class I molecule mamu-A*01: implications for vaccine design and testing.Identification of dominant optimal HLA-B60- and HLA-B61-restricted cytotoxic T-lymphocyte (CTL) epitopes: rapid characterization of CTL responses by enzyme-linked immunospot assayHow can the cellular immune response control hepatitis B virus replication?Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapyControl or persistence of hepatitis B virus: the critical role of initial host-virus interactions.Parallel decline of CD8+CD38+ lymphocytes and viremia in treated hepatitis B patients.Design of multi-epitope, analogue-based cancer vaccines.HLA class I allele promiscuity revisited.Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis.High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis BImmunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patientsRational design of a multiepitope vaccine encoding T-lymphocyte epitopes for treatment of chronic hepatitis B virus infections.Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.Host ethnicity and virus genotype shape the hepatitis B virus-specific T-cell repertoire.Extensive HLA class I allele promiscuity among viral CTL epitopes.Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospective.Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi.A new unconventional HLA-A2-restricted epitope from HBV core protein elicits antiviral cytotoxic T lymphocytes.A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule.Selection of hepatitis B virus variants with aminoacid substitutions inside the core antigen during interferon-alpha therapy.Degenerate immunogenicity of an HLA-A2-restricted hepatitis B virus nucleocapsid cytotoxic T-lymphocyte epitope that is also presented by HLA-B51.Isolation and functional characterization of hepatitis B virus-specific T-cell receptors as new tools for experimental and clinical use.Cross-binding between Plasmodium falciparum CTL epitopes and HLA class I molecules.Differential binding of viral peptides to HLA-A2 alleles. Implications for human papillomavirus type 16 E7 peptide-based vaccination against cervical carcinoma.Adaptation of the hepatitis B virus core protein to CD8(+) T-cell selection pressure.Widespread impact of HLA restriction on immune control and escape pathways of HIV-1An asymmetric model of heterozygote advantage at major histocompatibility complex genes: degenerate pathogen recognition and intersection advantageA mutant HBs antigen (HBsAg)183-191 epitope elicits specific cytotoxic T lymphocytes in acute hepatitis B patients.Mhc supertypes confer both qualitative and quantitative resistance to avian malaria infections in a wild bird population.Tools of the trade in vaccine design.Ramifications of HLA class I polymorphism and population genetics for vaccine development.Physicochemical explanation of peptide binding to HLA-A*0201 major histocompatibility complex: A three-dimensional quantitative structure-activity relationship study
P2860
Q24294775-F33A556C-C75B-4EB2-BA92-E3C855D8C4AFQ26781165-17AB5E85-4681-41AB-8642-A2FFB62BB08CQ27684538-B9EC190B-75EE-4C2A-A5F2-DB6DC22EE451Q30814677-B00149A6-B9A7-438D-B3C8-714F05891E5EQ33300465-3B64047D-57C4-4841-80D4-82DAD2EB22F0Q33315730-0B2CD461-BA1B-4B68-B415-3796904DFE8AQ33375075-B92D5F11-9805-44F7-8639-7053E165614CQ33835440-0DAA7037-68C5-44C6-A68F-DD57051B459FQ33874266-2DF000BC-3871-4E7B-A4FB-44500619A66AQ34022674-458957A8-D8B7-4B0A-80CF-20E978A6ED06Q34151071-A7638779-5A28-4EE9-8F51-CE2F6E493BF6Q34546460-086D5F11-31F4-4576-82CA-C597058CBDABQ34975716-EDB73BB2-F45D-4039-80F9-9117F610CE6FQ35207535-D40602E5-3683-48DD-B512-F6387AA13193Q35301640-E1B6661F-A461-45C0-94C0-3FD070E6249FQ35406362-F17156E2-59CA-4855-A9C6-0FAAAEC47D3FQ35597143-5D1BEC87-84FD-4796-A78F-D5E9FAFE2596Q35829691-533CBB77-E833-479F-812E-FD19FBF4C5B5Q35857548-A2FA9BEA-3171-4CC1-9C77-34CE3FC57276Q36423998-7F2FE942-74EF-424D-AB9E-ABD967CB0257Q36898071-33529740-26E6-4A00-AA06-D6AB7535BAE6Q36949834-E34B2C9D-3571-4A88-B0A4-612E83949C63Q37066721-E67DD743-38CD-49B0-9921-1438739564E8Q37195244-BF83A839-2D6D-47EE-8D57-B67E168B3EF6Q37387851-08DEEC27-9719-4028-B1BD-624AEB717401Q37689242-979951E0-BBDB-4F7B-9746-3ADDA8C5257DQ39289753-AFEE9699-F15D-4A42-BF12-81E53E84F19AQ39376578-43BA29C7-CB1A-44EF-AF46-41D6CBB769C8Q39606035-3E09C034-A92A-424C-923A-120F8FA29F19Q40089302-F18630DA-A4E8-418C-BA4A-494DCECB9C2EQ40651254-15EA8A8D-DC64-4275-A26B-EF26A5091DFFQ40956450-047A5EA5-A3C0-45E4-A797-A15203E2FCADQ41462634-A3638DB6-7522-4C6A-9B22-843A8C4CB554Q41814777-4DCB82B1-106A-40FF-8A1D-B554D78EBB37Q42084853-8D957755-89F3-42CA-9A15-48A2A52BE5B0Q46783012-B3776974-01EE-4427-9C67-58EABA3B5F53Q51534687-B7096534-B40A-447D-9CFC-6FCC7B60BAB1Q52068268-B006F51D-8C89-45D3-9E1E-1A2BCB0F340AQ52070060-E7CBB1E9-A35B-45FC-9D6F-A9222CCAB39CQ57021685-CF74A013-DBFA-4265-9DB8-FF112790C102
P2860
Human histocompatibility leukocyte antigen-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Human histocompatibility leuko ...... patients with acute hepatitis.
@en
Human histocompatibility leuko ...... patients with acute hepatitis.
@nl
type
label
Human histocompatibility leuko ...... patients with acute hepatitis.
@en
Human histocompatibility leuko ...... patients with acute hepatitis.
@nl
prefLabel
Human histocompatibility leuko ...... patients with acute hepatitis.
@en
Human histocompatibility leuko ...... patients with acute hepatitis.
@nl
P2093
P2860
P356
P1476
Human histocompatibility leuko ...... patients with acute hepatitis.
@en
P2093
P2860
P304
P356
10.1172/JCI119559
P407
P577
1997-08-01T00:00:00Z